| Title | European Pharmaceutical Law Review |
| Abbreviation | Eur. Pharm. Law Rev. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Law (Q3); Pharmaceutical Science (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Drug Discovery (Q4) |
| h-index | 4 |
| Overall Rank/Ranking | 22210 |
| SCImago Journal Rank (SJR) | 0.162 |
| Impact Score | 0.20 |
| Publisher | Lexxion Verlagsgesellschaft mbH |
| Country | Germany |
| ISSN | 25117157, 25117181 |
| Best Quartile | Q3 |
| Coverage History | 2019-2022 |
European Pharmaceutical Law Review is a journal covering the technologies/fields/categories related to Law (Q3); Pharmaceutical Science (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Drug Discovery (Q4). It is published by Lexxion Verlagsgesellschaft mbH. The overall rank of European Pharmaceutical Law Review is 22210. According to SCImago Journal Rank (SJR), this journal is ranked 0.162. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 4. The best quartile for this journal is Q3.
The ISSN of European Pharmaceutical Law Review journal is 25117157, 25117181. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. European Pharmaceutical Law Review is cited by a total of 19 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of European Pharmaceutical Law Review is 0.20, which is computed in 2024 as per its definition. European Pharmaceutical Law Review IF is increased by a factor of 0.01 and approximate percentage change is 5.26% when compared to preceding year 2022, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of European Pharmaceutical Law Review is 0.20. If the same upward trend persists, Impact IF may rise in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.20 |
| 2022 | 0.19 |
| 2021 | 0.07 |
| 2020 | 0.00 |
| 2019 | 0.00 |
European Pharmaceutical Law Review has an h-index of 4. It means 4 articles of this journal have more than 4 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of European Pharmaceutical Law Review is 25117157, 25117181. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of European Pharmaceutical Law Review is 22210. According to SCImago Journal Rank (SJR), this journal is ranked 0.162. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.162 |
| 2022 | 0.116 |
| 2021 | |
| 2020 | |
| 2019 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 22210 |
| 2022 | 24572 |
| 2021 | 27292 |
| 2020 | 33295 |
| 2019 | 30894 |
European Pharmaceutical Law Review is published by Lexxion Verlagsgesellschaft mbH. It's publishing house is located in Germany. Coverage history of this journal is as following: 2019-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of European Pharmaceutical Law Review is Eur. Pharm. Law Rev.. This abbreviation ('Eur. Pharm. Law Rev.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Law (Q3); Pharmaceutical Science (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Drug Discovery (Q4), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
European Pharmaceutical Law Review latest impact IF is 0.20. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 0.20 (2023) and 0.00 (2020), respectively, in the last 5 years. Moreover, its average IS is 0.09 in the previous 5 years.
The European Pharmaceutical Law Review has an SJR (SCImago Journal Rank) of 0.162, according to the latest data. It is computed in the year 2024. In the past 5 years, this journal has recorded a range of SJR, with the highest being 0.162 in 2023 and the lowest being in 2021. Furthermore, the average SJR of the European Pharmaceutical Law Review over the previous 5-year period stands at 0.09.
The latest h-index of the European Pharmaceutical Law Review is 4.
The European Pharmaceutical Law Review is published by the Lexxion Verlagsgesellschaft mbH, with its country of publication being the Germany.
The European Pharmaceutical Law Review is currently ranked 22210 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 5 years, this journal has experienced varying rankings, reaching its highest position of 22210 in 2023 and its lowest position of 33295 in 2020.
The standard ISO4 abbreviation for the European Pharmaceutical Law Review is Eur. Pharm. Law Rev..
European Pharmaceutical Law Review is classified as a journal that the Lexxion Verlagsgesellschaft mbH publishes.
The European Pharmaceutical Law Review encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The European Pharmaceutical Law Review is assigned the following International Standard Serial Numbers (ISSN): 25117157, 25117181.
The best quartile for the European Pharmaceutical Law Review is Q3 (2023).
The European Pharmaceutical Law Review coverage history can be summarized as follows: 2019-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Dermatologia Kliniczna | journal | 25442 | Cornetis | 7 | 0.00 |
| Zeitschrift fur Germanistische Linguistik | journal | 14988 | Walter de Gruyter GmbH | 16 | 0.40 |
| Clinical Medicine and Research | journal | 14722 | Marshfield Clinic | 62 | 1.02 |
| Milan Journal of Mathematics | journal | 3538 | Birkhauser Verlag Basel | 29 | 1.14 |
| Materials Research | journal | 15375 | Universidade Federal de Sao Carlos | 71 | 1.46 |
| Journal, Indian Academy of Clinical Medicine | journal | 26979 | Indian Academy of Clinical Medicine | 16 | 0.10 |
| Sex Education | journal | 7722 | Routledge | 45 | 2.66 |
| Tekstilec | trade journal | 18966 | University of Ljubljana Press | 15 | 0.91 |
| SPE International Formation Damage Control Symposium Proceedings | conference and proceedings | 21934 | 16 | 0.00 | |
| Consulting engineer Barrington | journal | 24079 | Cahners Pub. Co. | 0 | 0.00 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 0.20 |
| 2022 | 0.19 |
| 2021 | 0.07 |
| 2020 | 0.00 |
| 2019 | 0.00 |
